Not Tagged
Not Tagged
['car-t', 'lymsm']
for r/r disease, there are multiple options: car-t (including in 2l if primary refractory and relapse &lt;12 months), tafa-len, pola-br, and lonca. outcomes data are below. #lymsm #asco22 
Heme/onc fellow. #lymsm & #mmsm patient-reported outcomes researcher. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????